Survey on the rising use of Inter Partes Reviews to challenge patents reveals key considerations for originator companies.
Eva Freel
Advertisement
Articles by Eva Freel
Advertisement
Latest Updated Articles
New Challenge to IP InnovationPublished: October 1st 2016 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Pharmaceutical Commercialization: A 2026 Outlook Personalization and Precision Will Define a New Year in Pharma
3
FDA Announces Agency-Wide Deployment of Agentic AI Tools
4
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
5
